Dr.Reddy's Pharmaceutical Company - One of the best in Worlds pharmaceutical companies
Dr. Reddy's Leadership Model
 
Dr.Reddy's Corporate Social Responsibility
 
The first Indian manufacturing company
                                                    to be SOX-certified
  Stock Info
We are committed to delivering long-term enrichment to our stakeholders.

Since its inception in 1984, Dr. Reddy's has chosen to walk the path of discovery and innovation in health sciences. Ours has been a quest to sustain and improve the quality of life, and we have had nearly two decades of creating safe pharmaceutical solutions with the ultimate purpose of making the world a healthier place. Our competencies cover the entire pharmaceutical value chain – API and Intermediates, Finished Dosages (Branded and Generic) and NCE Research.

Our research centre uses cutting-edge technology and has discovered breakthrough pharmaceutical solutions in select therapeutic areas. In a short span of operations, we have filed for more than 75 patents. We are the first Indian company to out-license an NCE molecule for clinical trials. To strengthen our research arm, we have set up a research subsidiary, Reddy US Therapeutics Inc., in Atlanta, USA.

  STOCK EXCHANGES

New York Stock Exchange (NYSE) (ADR listed)
National Stock Exchange (NSE)
Bombay Stock Exchange (BSE)

Shares are also traded in other stock exchanges as permitted securities. Options being traded on select international exchanges.

  STOCK TICKERS

Bombay Stock Exchange (BSE)
  500124
National Stock Exchange (NSE)
  DRREDDY
New York Stock Exchange (NYSE)
  RDY
Reuters
  REDY.BO
Bloomberg
  DRRD@IN
International Securities Identification
Number (ISIN)
  INE 089 AO 1023
CUSIP number
  256135203

  Stock Charts
Stock chart
Designed by Bodhtree Product engineering outsourcing
© 2001 - 2008 Dr. Reddy's Laboratories Ltd. All rights reserved
Site best viewed at 800x600 resolution